Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-24T16:15:16.169Z Has data issue: false hasContentIssue false
  • English
  • Français

A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes

Published online by Cambridge University Press:  01 December 2008

Fabiana Cerrato ,
Giuseppe Pacileo ,
Giuseppe Limongelli ,
Maria Giulia Gagliardi ,
Giuseppe Santoro ,
Maria Cristina Digilio ,
Giovanni Di Salvo ,
Rachele Ardorisio ,
Tiziana Miele  and
Raffaele Calabrò
Fabiana Cerrato*
Affiliation:
Division of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy
Giuseppe Pacileo
Affiliation:
Division of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy
Giuseppe Limongelli
Affiliation:
Division of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy
Maria Giulia Gagliardi
Affiliation:
Division of Paediatric Cardiology, Bambino Gesù Hospital, Rome, Italy
Giuseppe Santoro
Affiliation:
Division of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy
Maria Cristina Digilio
Affiliation:
Division of Paediatric Cardiology, Bambino Gesù Hospital, Rome, Italy
Giovanni Di Salvo
Affiliation:
Division of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy
Rachele Ardorisio
Affiliation:
Division of Paediatric Cardiology, Bambino Gesù Hospital, Rome, Italy
Tiziana Miele
Affiliation:
Division of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy
Raffaele Calabrò
Affiliation:
Division of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy
*
Correspondence to: Fabiana Cerrato, MD, Via G. De Caro 47, 84126, Salerno, Italy. Tel: 328 834 1479; Fax: 081 706 4275; E-mail: fabianacerrato@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Several clinical and echocardiographic studies describe morphological and functional findings in patients with hypertrophic cardiomyopathy. Less is known regarding morphological and functional characteristics of the left ventricular hypertrophy found in the setting of the Noonan and LEOPARD syndromes.

Objective

To compare non-invasively the morphological and functional findings potentially affecting symptoms and clinical outcome in children with hypertrophic cardiomyopathy as opposed to Noonan and LEOPARD syndromes.

Patients and methods

We studied by echo-Doppler 62 children with left ventricular hypertrophy, dividing them into two subgroups matched for age and body surface area. The first group, of 45 patients with a mean age of 7.5 ± 5.2 years and body surface area of 0.9 ± 0.44 mq, had idiopathic hypertrophic cardiomyopathy. The second group, of 17 patients, all had left ventricular hypertrophy in the setting of Noonan or LEOPARD syndromes. Their mean age was 6.6 ± 5 years, and body surface area was 0.8 ± 0.36 mq. In all patients, we assessed the left ventricular maximal mural thickness, expressed as a Z-score, along with any obstructions in the left and right ventricular outflow tracts. In addition, to define left ventricular diastolic function, we used mitral flow and pulsed Tissue Doppler to record the Ea, Aa, Ea/Aa, E/Ea indexes in the apical 4-chamber view at the lateral corner of the mitral annulus. We also measured the diameters of the coronary arteries in the diastolic frame.

Results

Compared to those with hypertrophic cardiomyopathy, those with syndromic left ventricular hypertrophy showed a significantly increased Z-score for mural thickness, and a higher prevalence of obstruction in the left ventricular outflow tract. In addition, the patients with Noonan or LEOPARD syndromes showed a significantly decrease of Ea and increase of Aa, with a decreased Ea/Aa ratio, all suggestive of left ventricular abnormal relaxation. Moreover, the E/Ea ratio was significantly increased in these patients. The presence of right ventricular hypertrophy, mainly associated with dynamic obstruction in the outflow tract, was detected in only 5 of the 17 patients with Noonan or LEOPARD syndromes, as was dilation of the coronary arteries.

Conclusions

Compared to children with hypertrophic cardiomyopathy, those with left ventricular hypertrophy in the setting of Noonan or LEOPARD syndromes show more ventricular hypertrophy and diastolic dysfunction, due to both abnormal relaxation and reduced compliance. They also exhibit an increased prevalence of obstruction of the left ventricular outflow tract, along with dynamic obstruction of the right ventricular outflow tract and dilated coronary arteries. These morphological and functional findings could explain the different symptoms and clinical events, and potentially define the more appropriate therapeutic options in children with left ventricular hypertrophy of different aetiology.

Keywords

Myocardial hypertrophyobstructed ventricular outflow tractssyndromes
Type
Original Article
Information
Cardiology in the Young , Volume 18 , Issue 6 , December 2008 , pp. 575 - 580
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Maron, BJ, Gottdiener, JS, Epstein, SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418–428.CrossRefGoogle ScholarPubMed
2.Klues, HG, Shiffers, A, Maron, BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995; 26: 1699–1700.CrossRefGoogle ScholarPubMed
3.Maron, B. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287: 1308–1320.CrossRefGoogle ScholarPubMed
4.Chung, MW, Tsoutsman, T, Semsariuan, C. Hypertrophic cardiomyopathy: from gene defect to clinical disease. Cell Res 2003; 13: 9–20.CrossRefGoogle ScholarPubMed
5.Bonne, G, Carrier, L, Richard, P, et al. Familial Hypertrophic cardiomyopathy from mutations to functional defects. Circ Res 1998; 83: 580–593.CrossRefGoogle ScholarPubMed
6.Moolman, JC, Corfield, VA, Posen, B, et al. Sudden death due to troponin T mutations. J Am Coll Cardiol 1997; 29: 549–555.CrossRefGoogle ScholarPubMed
7.Tartaglia, M, Mehler, EL, Goldberg, R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001; 29: 465–468.CrossRefGoogle ScholarPubMed
8.Pandit, B, Sarkozy, A, Pennacchio, LA, Carta, C, et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 2007; 39: 1007–1012.CrossRefGoogle ScholarPubMed
9.Sarkozy, A, Schirinzi, A, Lepri, F, et al. Clinical lumping and molecular splitting of LEOPARD and NF1/NF1-Noonan syndromes. Am J Med Genet A 2007; 143: 1009–1011.CrossRefGoogle Scholar
10.Tartaglia, M, Pennacchio, LA, Zhao, C, et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 2007; 39: 75–79.CrossRefGoogle Scholar
11.Nagueh, SF, Middleton, KJ, Kopelen, HA, et al. Doppler tissue imaging: a non-invasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527–1533.CrossRefGoogle Scholar
12.Nagueh, SF, Lakkis, NM, Middleton, KJ, et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999; 99: 254–261.CrossRefGoogle ScholarPubMed
13.Matsumura, Y, Elliott, PM, Virdee, MS, et al. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Heart 2002; 87: 247–251.CrossRefGoogle ScholarPubMed
14.Rajiv, C, Vinereanu, D, Fraser, AG. Tissue Doppler imaging for the evaluation of patients with hypertrophic cardiomyopathy. Curr Opin Cardiol 2004; 19: 430–436.CrossRefGoogle ScholarPubMed
15.McMahon, CJ, Nagueh, SF, Pignatelli, RH, et al. Characterization of left ventricular diastolic function by Tissue Doppler Imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation 2004; 109: 1–7.CrossRefGoogle ScholarPubMed
16.Van der Burgt, I, Berends, E, Lommen, E, et al. Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet 1994; 53: 187–191.CrossRefGoogle Scholar
17.Voron, DA, Hatfield, HH, Kalkhoff, RK. Multiple lentigines syndrome. Case report and review of the literarature. Am J Med 1976; 60: 447–456.CrossRefGoogle Scholar
18.Digilio, MC, Sarkozy, A, de Zorzi, A, et al. LEOPARD syndrome: clinical diagnosis in the first year of life. Am J Med Genet A 2006; 140: 740–746.CrossRefGoogle ScholarPubMed
19.Shapiro, LM, McKenna, WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983; 2: 437–444.CrossRefGoogle ScholarPubMed
20.McKenna, WJ, Kleinebenne, A, Nihoyannopoulos, P, et al. Echocardiographic measurement of right ventricular wall thickness in hypertrophic cardiomyopathy: relation to clinical and prognostic features. J Am Coll Cardiol 1988; 11: 351–358.CrossRefGoogle ScholarPubMed
21.Musewe, NN, Robertson, MA, Benson, LN, et al. The dysplastic pulmonary valve: echocardiographic features and results of balloon dilatation. Br Heart J 1987; 57: 364–370.CrossRefGoogle ScholarPubMed
22.Houston, AB, Sheldon, CD, Simpson, IA, et al. The severity of pulmonary valve or artery obstruction in children estimated by Doppler ultrasound. Eur Heart J 1985; 6: 786–790.CrossRefGoogle ScholarPubMed
23.Limongelli, G, Pacileo, G, Marino, B, et al. Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. Am J Cardiol 2007; 100: 736–741.CrossRefGoogle ScholarPubMed
24.De Zorzi, A, Colan, SD, Gauvreau, K, et al. Coronary artery dimensions may be classified as normal in Kawasaki disease. J Pediatr 1998; 133: 254–258.CrossRefGoogle ScholarPubMed
25.Henry, WL, Ware, J, Gardin, JM, et al. Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood. Circulation 1978; 57: 278.CrossRefGoogle ScholarPubMed
26.Nishikawa, T, Ishiyama, S, Shimojo, T, et al. Hypertrophic cardiomyopathy in Noonan syndrome. Acta Paediatrica Japonica 1996; 38: 91–98.CrossRefGoogle ScholarPubMed
27.Takahashi, K, Kogaki, S, Kurotobi, S, et al. A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy. Eur J Pediatric 2005; 164: 497–500.CrossRefGoogle Scholar
28.Pearl, W. Cardiovascular anomalies in Noonan’s syndrome. Chest 1977; 71: 677–679.CrossRefGoogle ScholarPubMed
29.Krams, R, Kofflard, MJ, Duncker, DJ, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodelling of the coronary microcirculation. Circulation 1998; 97: 230–233.CrossRefGoogle ScholarPubMed
30.Loukas, M, Dabrowski, M, Kantoch, M, et al. A case report of Noonan’s syndrome with pulmonary valvar stenosis and coronary aneurysms. Med Sci Monit 2004; 10: CS80–CS83.Google ScholarPubMed
31.Burch, M, Mann, J, Sharland, M, et al. Myocardial disarray in Noonan syndrome. Br Heart J 1992; 325: 1753–1760.Google Scholar
32.Ostman-Smith, I, Wettrell, G, Keeton, B, et al. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high risk of dying suddenly. Cardiol Young 2005; 15: 632–642.CrossRefGoogle ScholarPubMed